DPA
AVNS icon

Delphi Private Advisors’s Avanos Medical AVNS Stock Holding History

Delphi Private Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2
Closed – – 112
2016
Q4 		$0 Hold
2
– – ﹤0.01% 280
2016
Q3 		$0 Hold
2
– – ﹤0.01% 461
2016
Q2 		$0 Hold
2
– – ﹤0.01% 491
2016
Q1 		$0 Hold
2
– – ﹤0.01% 321
2015
Q4 		$0 Buy
+2
New +$62 ﹤0.01% 369

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Delphi Private Advisors's AVNS Position: Q1 2017 in Review

Delphi Private Advisors sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 2 shares.

Delphi Private Advisors first reported a position in AVNS in Q4 2015 and held it in 5 quarters. The position peaked at $0 in Q4 2016. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • Delphi Private Advisors reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • Delphi Private Advisors sold 2 Avanos Medical shares in Q1 2017.
  • Delphi Private Advisors first reported a position in Avanos Medical in Q4 2015 and held it in 5 quarters.
  • Delphi Private Advisors's Avanos Medical position peaked at $0 in Q4 2016.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on Delphi Private Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.